PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Department of Clinical Neurosciences, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.\', \'Department of Neurology, Colentina Hospital, Bucharest, Romania.\', \'Department of Neurology, Queen\'s Medical Centre, Nottingham University Hospitals, Nottingham, UK.\', \'Department of Multiple Sclerosis and Neuroimmunology, CHU Grenoble, Grenoble, France.\', \'Academic Clinical Neurology, Division of Clinical Neuroscience, C Floor, South Block, Queen\'s Medical Centre, Derby Road, NG7 2UH, Nottingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/qjmed/hcaa348
?:doi
?:hasPublicationType
?:journal
  • QJM : monthly journal of the Association of Physicians
is ?:pmid of
?:pmid
?:pmid
  • 33486513
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33486513>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33486513>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all